Article 18 Oct 2023 SEC Announces Charges Against Insiders For Reporting Failures And Adopts Amendments To Schedule 13D And 13G Report Filing Timelines United States Commercial
Article 04 Sep 2023 Reclassifying Cannabis As A Schedule III Substance – Will The DEA Agree? United States Cannabis
Article 22 Nov 2022 Nasdaq, FINRA And NYSE Issue Warnings Of Small-Cap IPO Fraud United States Commercial
Article 18 Nov 2020 SEC Adopts Rule Amendments Aimed At Expanding Access To Capital United States Coronavirus
Article 14 May 2020 Exchange Relief: NYSE Provides Partial Waiver For Shareholder Approval Of PIPE Transactions; Nasdaq Provides Relief Regarding Continued Listing Requirements United States Coronavirus
Article 07 Feb 2019 Expansion Of Regulation A To Reporting Companies: Increased Alternatives Now Available To Public Companies Seeking To Raise Capital Or For Mergers And Acquisitions United States Commercial
Article 14 Sep 2018 Recent Development In Regulatory Enforcement Of Digital Securities United States Commercial